Trial Profile
A post marketing surveillance of Deferasirox in patients with transfusional hemosiderosis in a real world setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Haemosiderosis
- Focus Adverse reactions
- 15 Sep 2016 New trial record